Connect with us

Technology

Biologit Boosts Patient Safety with World-First Automated Local Literature Monitoring Solution for Non-Indexed Sources

Published

on

* Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable. * The new managed service, already live at a top 10 pharma company, harnesses a technology ingestion model built by Biologit to fill a critical gap in pharmacovigilance, at scale. *Local literature surveillance is a highly resource-intensive mandatory activity, with significant budget implications yet with relative low yield for safety events.

DUBLIN, April 2, 2025 /PRNewswire-PRWeb/ — Biologit, a specialist in advanced, technology-enabled safety surveillance solutions for life sciences, has launched a world-first automation solution for local literature monitoring. Biologit for Local Literature™ solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country-specific publications.

This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now.

The new managed data service, which is already live at a top 10 global biopharma company, fills a critical gap in current international safety surveillance. That’s because a significant proportion of adverse events first come to light via discrete local medical publications and online sources that are not picked up by routine open-source global literature searches. The activity’s critical importance is recognised by regulators, which mandate that pharma companies screen for safety events in all relevant markets.

The traditional screening process for local medical literature is inefficient and unreliable:

Highly manual and time-consuming, it requires dedicated staff at an affiliate or regional level;It yields only limited safety information. Errors and omissions are common;These issues are compounded by inconsistency in the format, indexing; access issues (e.g. paid subscriptions/print-only formats); language barriers; and variances in regulators’ reporting expectations.

Biologit for Local Literature uses advanced technology to overcome this challenge, efficiently, reliably and at scale. It has been shown to yield a 15-fold acceleration in safety event reporting when applied to a broad spectrum of local sources across 30 EU countries, with impressive accuracy.

Optimised algorithms, closely governed

Biologit for Local Literature uses a technology-based ingestion model developed by Biologit’s expert engineers. Each source is evaluated, and proprietary technology methods (including optimised algorithms that act as automated ‘crawlers’ per site) are used to support the ingest of any non-indexed in-country literature source as required. Even hard-to-reach print sources, conference proceedings and websites are included. As part of the managed service, Biologit’s operations team then confirms the findings manually, balancing process innovation with strong governance to contain any risk and ensure the product is audit-ready.

This innovative solution complements the company’s existing Biologit Database™, an extensive and continuously updated range of indexed, open-source global, regional and national medical publications and online resources. The ability to screen more diverse, non-standardised local sources in a reliable and highly efficient way – and filter searches by country – via Biologit’s new bespoke managed data service, rounds off the solution suite.

The combined 360-degree screening is powered by Biologit Platform™, Biologit’s powerful scientific literature monitoring platform, which features flexible workflow and unique AI productivity features. Biologit for Local Literature removes the final source of pain and risk from literature monitoring, raising the overall benefit to patient safety. ALL safety events are accessible via a single window, or query.

Delivered via the Biologit Platform, Biologit for Local Literature covers all countries and includes automated machine translation for hundreds of languages. The innovative technology allows for country-level data filtering for specific local searches, and individual country reporting and audit trails. It also supports single, integrated searches for global and local safety events.

Commenting on the significance of Biologit for Local Literature, Nicole Baker, Biologit’s CEO and co-founder, said:

“This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now. Worse than that, it hasn’t delivered. This world-first, tech-enabled managed service ensures accurate and complete coverage for all journals, websites and subscription-based publications of interest in a country, delivered with unprecedented efficiency.

“Our use of automation allows us to do this at scale. This is not about assigning large service teams, or trying to track everything in spreadsheets. With Biologit for Local Literature we harness technology including specially-developed crawlers which are fast and reliable, and everything is properly overseen by our skilled people, to verify the accuracy and reliability of the output. Given the high sensitivity of patient safety, and the strict PV/Regulatory requirements, we have taken great pains to balance innovation and risk, and the results are exceeding all expectations.”

A new white paper, A World First: Integrated, Automated Global & Local Literature Monitoring for Pharmacovigilance is available for download on the Biologit website here. To arrange a 1:1 demonstration please email jean.redmond@biologit.com.

About Biologit

Biologit is an innovator in pharmacovigilance (PV), revolutionising the way that life science organisations handle literature review and monitoring, using cutting-edge automation technology wherever appropriate. Founded with a mission to enhance patient safety and operational efficiency, Biologit empowers pharmaceutical, biotech and PV service providers to simplify and streamline their processes. At the heart of Biologit’s Platform is its AI-powered literature automation tool, designed to transform manual and time-intensive tasks into seamless, efficient workflows. Biologit adheres to the highest industry standards, including ISO 27001 certification, GxP compliance, and alignment with FDA regulations.

PR Contact

Carina Birt, Sarum Life Sciences

carina@sarumlifesciences.com

+44 7970 006624

Media Contact

Jean Redmond, biologit, 44 00000000000, jean.redmond@biologit.com, https://www.biologit.com/

View original content:https://www.prweb.com/releases/biologit-boosts-patient-safety-with-world-first-automated-local-literature-monitoring-solution-for-non-indexed-sources-302417543.html

SOURCE biologit

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Electrolux Group to end production in Jászberény, Hungary

Published

on

By

STOCKHOLM, April 22, 2026 /PRNewswire/ — Electrolux Group has decided to end production at the Jászberény, Hungary factory, which manufactures built-in and freestanding refrigeration products. Production is expected to cease by the end of 2026. A restructuring charge of approximately SEK 0.6 billion, of which SEK 0.3 billion is cash related, will be reported as a negative non-recurring item affecting operating income for Region Europe, Middle East & Africa and Asia-Pacific in the second quarter of 2026.

The decision follows a review of the company’s strategy to strengthen cost competitiveness and increase agility through production footprint optimization. This is driven by the current competitive environment, which is impacted by stagnant market demand, price pressure, and increasing constraints on cost competitiveness. The planned site closure will impact approximately 600 employees.

Electrolux Group will fully meet demand for refrigeration products by leveraging existing operations as well as working with external OEM partners. The decision does not affect the local sales and marketing activities managed by the Budapest office. 

This is information that AB Electrolux is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 22-04-2026 08:30 CET.

For more information:

Ann-Sofi Jönsson, Head of Investor Relations & Sustainability Reporting, +46 73 025 1005

Maria Åkerhielm, Investor Relations Manager, +46 70 796 3856

Henry Sjölin, Investor Relations Manager, +46 76 863 51 85

Electrolux Group Press Hotline, +46 8 657 65 07

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/electrolux-group/r/electrolux-group-to-end-production-in-jaszbereny–hungary,c4337676

The following files are available for download:

https://mb.cision.com/Main/1853/4337676/4051089.pdf

Press release Hungary April 22 2026 ENG final

 

View original content:https://www.prnewswire.com/news-releases/electrolux-group-to-end-production-in-jaszbereny-hungary-302749943.html

SOURCE Electrolux Group

Continue Reading

Technology

MediaGo and hipto Secure Another Les Cas d’Or Gold in Performance Marketing

Published

on

By

SAN FRANCISCO, April 22, 2026 /PRNewswire/ — Recently, MediaGo, a global intelligent advertising platform, and hipto, France’s premier lead generation specialist, won Gold in the “Content and Vertical Industries” category at the prestigious French digital marketing awards, Les Cas d’Or. Recognized for a benchmark performance marketing campaign in the health insurance sector, this award—voted on by over 40 brand marketing directors—serves as further authoritative validation of MediaGo’s technical prowess and service capabilities in the European market.

Following previous wins of Gold in the Native Advertising category and Bronze in the Banking & Insurance Acquisition category, this latest industry honor marks another significant milestone. It underscores that MediaGo’s localized native advertising capabilities, along with its ability to apply deep learning technologies in complex user acquisition scenarios across France and Europe, have earned high acclaim from both the market and industry experts, cementing its position at the forefront of the industry.

The French health insurance market is highly competitive and saturated. Local advertisers have long relied heavily on search and social media channels, resulting in persistently high CPAs and significant traffic inflation. Addressing these industry pain points, MediaGo and hipto collaborated to pioneer a new growth trajectory, establishing the open web as the third core acquisition pillar alongside search and social. By leveraging premium local news and information publishers in France, they seamlessly integrated native ads into media environments, providing the insurance sector with a scalable, replicable growth blueprint to effectively counter traffic inflation.

This award-winning campaign focused on scaling the acquisition of high-intent leads in the insurance sector. It successfully overcame three structural challenges inherent in traditional bidding models: reactive algorithms, high cold-start costs, and the difficulty of balancing scale with efficiency. This achievement further validates MediaGo’s strong operational capabilities and its innovation in native advertising within the French market.

Powered by five deep learning models and the newly upgraded SmartBid 3.0, MediaGo precisely predicts the conversion probability of each ad impression in real time. Paired with hipto’s high-frequency creative iterations (3–5 times per week), MediaGo continuously identifies high-potential audience clusters, further enhancing targeting precision. In addition, SmartBid 3.0’s unique “global learning” mechanism reduced the cold start learning cycle for new campaigns by 50%. This partnership enabled campaigns to achieve stable monetization from day one.

By utilizing SmartBid 3.0’s MaxCV mode, hipto’s campaigns achieved a dual breakthrough in both scale and efficiency. Data shows an immediate 32% uplift in monthly conversion volume and a threefold increase in lead volumes over the longer term, successfully expanding market share within a saturated vertical. Additionally, native ad CTR surpassed the industry benchmark by 53%, demonstrating the platform’s ability to precisely target high-intent users. Notably, even with a 48% increase in mobile budget allocation, CPA decreased by 2.6%, proving that volume scaling and margin preservation can coexist.

Leo Ye, Head of Partnerships at MediaGo, stated: “Winning the Les Cas d’Or Gold for Performance Marketing is a strong endorsement of MediaGo’s technical strength and localized service capabilities. We remain committed to a performance-driven, advertiser-centric approach, deepening our footprint in the French market to help advertisers break through growth bottlenecks in a saturated landscape.”

Looking ahead, MediaGo will continue to deepen its presence in Europe. With deep learning at its core, the platform aims to continuously enhance its native advertising capabilities and localized operations, delivering tangible value to global advertisers and empowering partners to achieve high-quality, sustainable business growth in complex market environments.

About MediaGo

MediaGo is a leading intelligent advertising platform. Based on deep learning algorithms, MediaGo empowers businesses of all scales, creating tangible value for companies. With 12 operational centers worldwide, MediaGo has successfully provided localized and comprehensive business growth services to over 10,000 partners.

Photo – https://mma.prnewswire.com/media/2961753/PRN.jpg

View original content:https://www.prnewswire.co.uk/news-releases/mediago-and-hipto-secure-another-les-cas-dor-gold-in-performance-marketing-302748643.html

Continue Reading

Technology

Dandelion Civilization launches a Human Intelligence Platform to make talent risk visible before it becomes expensive

Published

on

By

New Human Intelligence Platform helps employers assess role fit, team dynamics, and early behavioral risk to avoid costly talent decisions.

AMSTERDAM, April 22, 2026 /PRNewswire/ — Dandelion Civilization today announced the launch of its Human Intelligence Platform at HR Tech Europe 2026, introducing a new approach to talent management and workforce decision-making, built around behavioral intelligence rather than instinct alone.

The launch addresses a problem many organizations already understand but still struggle to solve. Talent mis-matches are expensive, early misalignment is difficult to correct, and quality of hire remains hard to improve because the real consequences often appear months after a decision is made. Industry estimates frequently place the total cost of hiring a new employee at several times the position’s salary, especially when poor fit leads to replacement, lost productivity, and disruption.

While much of the HR technology market has focused on the hiring stage itself, Dandelion Civilization is taking a different route. The platform is designed to help employers understand how people are likely to perform in real conditions by revealing how they think, act, and interact across hiring, team development, and workforce risk.

At the core of the platform is a behavioral intelligence layer that creates continuous, evolving profiles of individuals and teams. Rather than relying only on CVs, interviews, or static questionnaires, Dandelion Civilization uses behavioral simulations to surface signals around decision making, collaboration, pressure response, and alignment. According to the company’s launch materials, the product is built around three core areas: hiring intelligence, team dynamics, and behavioral risk. It is designed to support decisions before day one, strengthen visibility into how individuals affect team performance, and identify patterns that may point to conflict, disengagement, or misalignment before those issues damage business outcomes.

“We are not creating another assessment tool,” said Dmitry Zaytsev, Founder and CEO of Dandelion Civilization. “We are building the infrastructure for better talent decisions. Companies often discover the true cost of misalignment too late, when trust weakens, performance slips, or the hiring process has to begin again. We want to make those signals visible earlier, when organizations can still act on them.”

The company says the platform is designed to fit into existing workflows without technical friction. Employers send a link, candidates complete an online simulation, and talent teams receive a decision-ready report. The launch deck states that the simulation takes around 20 to 40 minutes, requires no integration, and works in any browser.

While the platform begins with hiring, Dandelion Civilization is positioning the launch as the first step toward a broader layer of human capital intelligence that can support team design, talent development, and earlier visibility into people related risk over time.

About Dandelion Civilization
Dandelion Civilization is building a Human Intelligence Platform that helps organizations understand how people think, act, and interact across the employment lifecycle. Using behavioral simulations and digital profiling, the platform supports hiring, team development, and earlier visibility into workforce risk. Its launch materials describe the product as a system designed to reduce talent blind spots and reveal behavior beyond profiles.

 

 

 

 

View original content:https://www.prnewswire.co.uk/news-releases/dandelion-civilization-launches-a-human-intelligence-platform-to-make-talent-risk-visible-before-it-becomes-expensive-302748410.html

Continue Reading

Trending